Radiotherapy plus immune checkpoint inhibitor in prostate cancer

The immune checkpoint inhibitor (ICI) is a promising strategy for treating cancer. However, the efficiency of ICI monotherapy limited, which could be mainly attributed to tumor microenvironment “cold” tumor. Prostate cancer, type most common cancer affecting men’s health. Radiotherapy regarded as one effective prostate treatments. In era therapy, enhanced antigen presentation and cell infiltration caused by radiotherapy might boost therapeutic efficacy ICI. Here, rationale combined with was reviewed. Also, scheme blockades suggested potential option improve outcome patients